The Aporia
Sweeney, E. (2026, October 15). Pathway Labs EchoNext. TIME. https://time.com/collection/best-inventions/2026/pathway-labs-echonext/
Sweeney, Erica. “Pathway Labs EchoNext.” TIME, 15 Oct. 2026, https://time.com/collection/best-inventions/2026/pathway-labs-echonext/.
Sweeney, Erica. “Pathway Labs EchoNext.” TIME, October 15, 2026. https://time.com/collection/best-inventions/2026/pathway-labs-echonext/.
Dated from the outlet's own feed. Check the original for its byline.
Dr. Pierre Elias, a medical director for AI at NewYork-Presbyterian and assistant professor of medicine and biomedical informatics at Columbia University, has developed EchoNext, an artificial intelligence tool that analyzes data from routine electrocardiograms to identify patients who need additional ultrasounds for diagnosing heart defects or abnormalities. A 2025 study demonstrated that EchoNext identified structural heart problems more accurately than cardiologists. The FDA granted clearance to EchoNext in June, and it will be available this year in multiple major health systems as well as through the AI medical platform OpenEvidence. Structural heart disease affects millions of people globally but often goes undetected until it progresses due to a lack of affordable routine screening options.